Iran is set to export medicine used to treat acute ischemic stroke Alteplase, also known as Altelyse, to foreign markets.
The knowledge-based company that produces the drug announced it has increased its production capacity to cater to foreign markets, besides supplying the domestic markets.
Hadi Hazrati, the director of the Biotechnology Department of the company said Oman, Venezuela, Iraq and Bosnia and Herzegovina are the target markets of the medicine.
Iran managed to break the US monopoly in producing the medicine last year and develop the drug which is a recombinant human tissue-type plasminogen activator that converts plasminogen to active plasmin and leads to fibrin clot dissolution.
Hazrati believes Altelyse is the best for people suffering from heart and cerebral strokes and pulmonary embolism by dissolving blood clots.
In case this drug is administered in its golden time, namely within 60 minutes after the onset of heart attack or stroke symptoms, it can save the patients’ life, he said.
Syria’s new rulers have appointed foreign and defense ministers, the official news agency SANA has…
Qatar has officially reopened its embassy in the Syrian capital Damascus after nearly 13 years.
Iranian nationals Mohammad Abedini and Mehdi Mohammad Sadeghi have been arrested in Milan and Massachusetts…
A tragic bus accident occurred on Saturday in Lorestan province, western Iran, killing seven soldiers…
Azerbaijani President Ilham Aliyev has expressed gratitude to Iranian President Massoud Pezeshkian in a letter,…
More than 12,300 civilian deaths have been recorded in Ukraine since Russia launched its full-scale…